Corrigendum to \"Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond\" [Crit. Rev. Oncol./Hematol. 200C (2024) 104404].
AuteursSirico M, Jacobs F, Molinelli C, Nader-Marta G, Debien V, Dewhurst HF, Pallesch M, Merloni F, Gianni C, De Giorgi U, de Azambuja E
Corrigendum to \"Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond\" [Crit. Rev. Oncol./Hematol. 200C (2024) 104404].
AuteursSirico M, Jacobs F, Molinelli C, Nader-Marta G, Debien V, Dewhurst HF, Pallesch M, Merloni F, Gianni C, De Giorgi U, de Azambuja E
Corrigendum to \"Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond\" [Crit. Rev. Oncol./Hematol. 200C (2024) 104404].
AuteursSirico M, Jacobs F, Molinelli C, Nader-Marta G, Debien V, Dewhurst HF, Pallesch M, Merloni F, Gianni C, De Giorgi U, de Azambuja E
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.
Auteursvan der Weyden L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino JM, Vermes I, Offord V, Droop A, Jones DRA, Anderson E, Hardy C, de Saint Aubain N, Ferguson PM, Mogler C, Rajan N, Frew D, Harms PW, Billings SD, Schatton D, Segarra-Mondejar M, Arends MJ, Ferreira I, Brenn T, Frezza C, Adams DJ
PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients.
AuteursLevy A, Berghmans T, Koller M, Fournier B, Mauer M, Andratschke N, Faivre-Finn C
